Financial Management Professionals, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Financial Management Professionals, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$39.62 - $69.97 $832 - $1,469	-21 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$58.09 - $82.51 $1,219 - $1,732	21 New	21 $1,000
Q3 2021 Nov 02, 2021	SELL	$58.38 - $84.96 $467 - $679	-8 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$62.15 - $90.32 $497 - $722	8 New	8 $1,000
Q4 2019 Jan 21, 2020	SELL	$28.14 - $73.01 $13,816 - $35,847	-491 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$17.43 - $28.82 $8,558 - $14,150	491 New	491 $13,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.76B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Management Professionals, Inc. with notifications on news.